Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-12-000459

← back to feed
Filed
Nov 13, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Sep 30, 2012 150M sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$1.14M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$90.3K
Stockholders Equity Q3 2012 · Sep 30, 2012 −$2.19M
Stockholders Equity Q3 2012 · Dec 31, 2011 −$1.93M
Total Liabilities Q3 2012 · Sep 30, 2012 $2.67M
Total Liabilities Q3 2012 · Dec 31, 2011 $2.34M
Current Assets Q3 2012 · Sep 30, 2012 $384
Current Assets Q3 2012 · Dec 31, 2011 $4.88K
Total Assets Q3 2012 · Sep 30, 2012 $485.79K
Total Assets Q3 2012 · Dec 31, 2011 $405.56K
Sga Expense Q3 2012 · Sep 30, 2012 $2.01M
Sga Expense Q3 2012 · Sep 30, 2011 $90.35K
Sga Expense Q3 2012 · Sep 30, 2011 $272.13K
Net Income Q3 2012 · Sep 30, 2012 −$2.18M
Net Income Q3 2012 · Sep 30, 2011 −$90.36K
Net Income Q3 2012 · Sep 30, 2011 −$273.81K
Cash And Equivalents Q3 2012 · Sep 30, 2011 $1.11K
Cash And Equivalents Q3 2012 · Dec 31, 2010 $3.13K